Agency information collection activities: Submission for OMB review; comment request,
Federal Register, June 25, 1998 (Nbr. Vol. 63, No. 122)
Notices - Centers for Disease Control and Prevention
Linked as:Federal Register, June 25, 1998 (Nbr. Vol. 63, No. 122)
Notices - Centers for Disease Control and Prevention
Linked as:Text
Federal Register: June 25, 1998 (Volume 63, Number 122)NoticesPage 34651-34652From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr25jn98-104
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
30DAY-16-98Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639-7090. Send written comments to CDC, Desk Officer; Human Resources and Housing Branch, New Executive Office Building, Room 10235; Washington, DC 20503. Written comments should be received within 30 days of this notice.
Proposed Projects
1. Breast Cancer Incidence in an Occupational Cohort Exposed to Ethylene Oxide and in an Occupational Cohort Exposed to Polychlorinated Biphenyls (0920-0366)--National Institute for Occupational Safety and Health (NIOSH)--Extension--Breast cancer is the most common incident cancer among U.S. women, and the second leading cause of cancer mortality in U.S. women. Increasing numbers of women are employed outside the home, yet few studies of breast cancer etiology have addressed occupational and environmental chemical exposures, and
[Page 34652]many cancer studies of industrial cohorts have excluded women. This study will provide information concerning: (1) the incidence of breast cancer in a cohort of women exposed to ethylene oxide (ETO), and (2) the incidence of breast cancer in a cohort of women exposed to polychlorinated biphenyls (PCBs). Both compounds are suspected breast carcinogens. These two cohorts have been previously assembled by NIOSH, and each represents the largest and best defined female study cohort in the U.S. for the respective exposure.
All women in the existing NIOSH ethylene oxide cohort (n=9,929) and PCB cohort (13,736) will be enrolled in the study. For both cohorts, data from personnel records has been coded into a computer file containing demographic, and work history information. This information will be used to estimate workplace exposures. Vital status has been determined through automated data sources. Questionnaires are currently being mailed to each living cohort member to obtain information on breast cancer incidence and risk factors for breast cancer. For deceased cohort members, next-of-kin will be asked to provide this information. Other record sources such as death certificates and population-based cancer incidence registries will also be used to identify cancer cases. The diagnosis will be confirmed by medical records. Each questionnaire will take approximately 30 minutes to complete. Total annual burden hours are 12,500.
Number of Avg. burden/ Total Respondents
Number of responses/ response burden (in respondents respondent (in hours) hours)
Workers..................................................... 23,000
1
.50 11,500 Medical providers...........................................
2,000
1
.50
1,000
2. Tests and Requirements for Certification and Approval of Respiratory Protective Devices--
NIOSH, in accordance with implementing regulations
Average
Number of Number of burden/ Total Respondents (section/data type)
respondents responses/ response burden (in respondent (in hours) hours)
84.11/Applications..........................................
56
14.0
63.56 49,831 84.33/Labeling..............................................
56
14.0
1.54
1,207 84.35/Modifications.........................................
56
14.0
79.45 62,289 84.41/Reporting.............................................
56
14.0
22.70 17,797 84.43/Record keeping........................................
56
14.0
56.75 44,492 84.257/Labeling.............................................
56
14.0
1.50
1,176 84.1103/Labeling............................................
56
14.0
1.50
1,176
Dated: June 18, 1998. Charles W. Gollmar, Acting Associate Director for Policy Planning and Evaluation, Centers for Disease Control and Prevention (CDC).
FR Doc. 98-16752Filed6-24-98; 8:45 amBILLING CODE 4163-18-P
If you are already a vLex customer, access here
This document cites
vlex
/
documento
23379854